Creating Hope Reauthorization Act of 2024

Bill: 118-s-4583
Sponsor: full_name: Sen. Casey, Robert P., Jr. [D-PA]
Introduced: 2024-06-18
Policy area: Health
Subjects: Child health

Drug safety, medical device, and laboratory regulation

Prescription drugs
Latest action: action_date: 2024-06-18
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:

tv_txt: II 118th CONGRESS 2d Session S. 4583 IN THE SENATE OF THE UNITED STATES June 18, 2024 Mr. Casey (for himself, Mr. Mullin , Mr. Brown , and Ms. Collins ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.

1. Short title This Act may be cited as the Creating Hope Reauthorization Act of 2024 . 2. Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360ff(b)(5) ) is amended by striking September 30, 2024, unless and all that follows through the period at the end and inserting September 30, 2030. .